This is a bi-monthly letter targeting identified problematic therapeutic issues (brief, simple, practical messages). The process involves a literature review and development of the message by different working groups of the Therapeutics Initiative. A draft of the letter is reviewed by specialists who are expert in the particular therapeutic area and members of the Scientific Information and Education Committee before the letter is disseminated. The Therapeutics Initiative is a member of the International Society of Drug Bulletins.